A Phase 3 randomized controlled multi-centre trial to evaluate the efficacy of the R21/Matrix-M vaccine in African children against clinical malaria
Taking a trip? We'll help you get connected with your local travel vaccination provider.
You are leaving this site and connecting to , part of the Precision Vax network.
You are leaving this site and connecting to , one of our carefully-selected partner sites.
Precision Vax may receive compensation for services rendered.
You are leaving this site and connecting to .
Precision Vax is not liable or responsible for the content, information, security, or failure of any products or services promoted or advertised on third party sites.